Literature DB >> 9635953

Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I.

T Chikama, K Fukuda, N Morishige, T Nishida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9635953     DOI： 10.1016/s0140-6736(98)24024-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  Differential contributions of impaired corneal sensitivity and reduced tear secretion to corneal epithelial disorders.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Mitsuru Sawa; Kazunori Miyata; Takaaki Matsui; Kyoko Shigeta
Journal:  Jpn J Ophthalmol       Date:  2011-11-11       Impact factor: 2.447

2.  Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects.

Authors:  R B Vajpayee; N Mukerji; R Tandon; N Sharma; R M Pandey; N R Biswas; N Malhotra; S A Melki
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

3.  Nerve growth factor modulates in vitro the expression and release of TGF-beta1 by amniotic membrane.

Authors:  Marco Coassin; Alessandro Lambiase; Alessandra Micera; Paola Tirassa; Luigi Aloe; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-13       Impact factor: 3.117

4.  The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on neurobiology.

Authors:  Fiona Stapleton; Carl Marfurt; Blanka Golebiowski; Mark Rosenblatt; David Bereiter; Carolyn Begley; Darlene Dartt; Juana Gallar; Carlos Belmonte; Pedram Hamrah; Mark Willcox
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-18       Impact factor: 4.799

5.  Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea.

Authors:  Fu-Shin Yu; Jia Yin; Patrick Lee; Frank S Hwang; Mark McDermott
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

Review 6.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

7.  Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.

Authors:  Ronald Mauricio Sanchez-Avila; Jesus Merayo-Lloves; Ana Cristina Riestra; Luis Fernandez-Vega Cueto; Eduardo Anitua; Leire Begoña; Francisco Muruzabal; Gorka Orive
Journal:  Int Ophthalmol       Date:  2017-06-15       Impact factor: 2.031

Review 8.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

Review 9.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

10.  Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Naoyuki Morishige; Ryoji Yanai; Naoyuki Yamada; Jun Saito
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.